Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage-Reference-Cited by-同舟云学术

Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage

Published:2022-01 Issue: Volume:162 Page:105563
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Gonzalez Selena,McHugh Tyne L.M.,Yang Tao,Syriani Wassim,Massa Stephen M.,Longo Frank M.,Simmons Danielle A.

Publisher

Elsevier BV

Subject

Neurology

Reference132 articles.

1. Restoration of motor learning in a mouse model of Rett syndrome following long-term treatment with a novel small-molecule activator of TrkB;Adams;Dis. Model. Mech.,2020

2. The role of CREB and BDNF in neurobiology and treatment of Alzheimer’s disease;Amidfar;Life Sci.,2020

3. Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein;Apelt;Brain Res.,2002

4. Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline;Ballinger;Neuron.,2016

5. The Trk family of neurotrophin receptors;Barbacid;J. Neurobiol.,1994

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease;Frontiers in Cellular Neuroscience;2024-09-02

2. Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer’s Disease;Pharmaceuticals;2024-07-28

3. Specific Mode Electroacupuncture Stimulation Mediates the Delivery of NGF Across the Hippocampus Blood–Brain Barrier Through p65-VEGFA-TJs to Improve the Cognitive Function of MCAO/R Convalescent Rats;Molecular Neurobiology;2024-07-12

4. Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease;Stem Cell Research & Therapy;2024-07-06

5. A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity‐dependent synaptic and microglial transcriptomic changes in a late‐stage Alzheimer's mouse model;Alzheimer's & Dementia;2024-05-23